GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Sale Of Business

Lupin (NSE:LUPIN) Sale Of Business : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Lupin Sale Of Business?

Lupin's sale of business for the three months ended in Dec. 2024 was ₹0 Mil. It means Lupin gained ₹0 Mil from selling business. Lupin's sale of business for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Sep. 2024 ), Lupin gained the same money from selling business in Dec. 2024 (₹0 Mil).

Lupin Sale Of Business Historical Data

The historical data trend for Lupin's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Sale Of Business Chart

Lupin Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,782.90 - - - -

Lupin Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lupin Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lupin Sale Of Business Related Terms

Thank you for viewing the detailed overview of Lupin's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Sale Of Business
Comparable Companies
BOM:532321 BOM:500124 BOM:543904 NSE:TORNTPHARM NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:500087 BOM:532296 BOM:524494 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
500257:India
Address
Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400055
Website
https://www.lupin.com
Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.

Lupin Headlines

No Headlines